Evidence map›Paper›PMID 37870640›Full record

ArticleEJNMMI radiopharmacy and chemistry2023

Dosimetry of [

Alexander Thiel, Alexey Kostikov, Hailey Ahn, Youstina Daoud, Jean-Paul Soucy, Stephan Blinder, Carolin Jaworski, Carmen Wängler, Björn Wängler, Freimut Juengling and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Alexander ThielJewish General Hospital and Lady Davis Institute for Medical Research, 3755 Chemin de la Cote St. Cathérine, Montreal, Québec, H3T 1E2, Canada. alexander.thiel@mcgill.ca.
Alexey KostikovDepartment of Neurology & Neurosurgery, McGill Univesrity, Montreal, Canada.
Hailey AhnJewish General Hospital and Lady Davis Institute for Medical Research, 3755 Chemin de la Cote St. Cathérine, Montreal, Québec, H3T 1E2, Canada.
Youstina DaoudJewish General Hospital and Lady Davis Institute for Medical Research, 3755 Chemin de la Cote St. Cathérine, Montreal, Québec, H3T 1E2, Canada.
Jean-Paul SoucyDepartment of Neurology & Neurosurgery, McGill Univesrity, Montreal, Canada.
Stephan BlinderBrain Imaging Center, Montreal Neurological Institute, Montreal, Canada.
Carolin JaworskiCross Cancer Institute, Medical Isotope Cyclotron Facility, University of Alberta, Edmonton, Canada.
Carmen WänglerBiomedical Chemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Björn WänglerMolecular Imaging and Radiochemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Freimut JuenglingNeuroscience and Mental Health Institute, University of Alberta, Edmonton, Canada.
Shirin A EngerJewish General Hospital and Lady Davis Institute for Medical Research, 3755 Chemin de la Cote St. Cathérine, Montreal, Québec, H3T 1E2, Canada.
Ralf SchirrmacherCross Cancer Institute, Medical Isotope Cyclotron Facility, University of Alberta, Edmonton, Canada.
McGill University · CAUniversity of Alberta · CAHeidelberg University · DEMontreal Neurological Institute and Hospital · CAConcordia University · CAJewish General Hospital · CA

Funding

Canadian Institutes for Health Research (CIHR) PJT169049
6 · The paper itself

Abstract

backgroundReduced expression or impaired signalling of tropomyosin receptor kinases (Trk receptors) are found in a vast spectrum of CNS disorders. [

resultsAverage organ absorbed dose was highest for liver and gall bladder with 6.1E-2 (± 1.06E-2) mGy/MBq and 4.6 (± 1.18E-2) mGy/MBq, respectively. Total detriment weighted effective dose E

conclusionTotal and organ-specific effective doses for [

Indexed as

[18F]TRACKDosimetryPositron emission tomographyTropomyosin receptor kinases

Identifiers

PMID37870640
PMCPMC10593718
OpenAlexW4387865827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.